ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
Volume 0.65M
Average 1.06M
ADRX Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
Net Margin history
Percent of revenue · from the income statement
No Net Margin data reported for this period type.
Net Margin vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | -151.1% | +333.8 pp | +673.9 pp | |
| LTM Mar 2026 | -173.5% | -123.0 pp | -102.4 pp | |
| LTM Mar 2026 | -255.7% | -148.7 pp | +3956.4 pp | |
| LTM Mar 2026 | -339.4% | -180.3 pp | +1527.3 pp | |
| FY2025 | -411.9% | — | — | |
| LTM Mar 2026 | -529.2% | -555.5 pp | +811.0 pp | |
| LTM Mar 2026 | -4917.6% | +334.9 pp | — | |
| LTM Mar 2026 | -9243.0% | — | -15619.4 pp | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — |
| FY2025 | — | — | — | |
| Peer median (excluding ADRX) | -375.6% | -135.8 pp | +742.4 pp | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.